Product Information
CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0177 per EA under NDC 00093342201. Its NADAC has been published 247 times since Oct 6, 2021.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093342201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071611On Market Since
7/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 247 times since Oct 6, 2021, and over the history we have for it it has declined 25.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0177 per EA |
|---|---|
| All-time high | $0.0267 (Mar 16, 2022) |
| All-time low | $0.0144 (Nov 20, 2024) |
| 52-week high | $0.0194 |
| 52-week low | $0.0176 |
| Median price | $0.0203 |
| Average price | $0.0205 |
| Largest weekly change | +32.5% (Jun 19, 2024) |
| Weeks tracked | 247 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0177 per EA (NDC 00093342201), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has declined 25.7%. It has been tracked across 247 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?
Since Oct 6, 2021, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0144 (Nov 20, 2024) to a high of $0.0267 (Mar 16, 2022), with a median of $0.0203 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 10 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 10 MG TABLET?
CYCLOBENZAPRINE 10 MG TABLET (NDC 00093342201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification